ASSESSMENT OF SUSPECTED HEPARIN INDUCED THROMBOCYTOPENIA MANAGEMENT IN A COMMUNITY TEACHING HOSPITAL: A RETROSPECTIVE STUDY Jonathan Gray, Hillary Holder, Mary Katherine Stuart, Sarah Blackwell Princeton Baptist Medical Center - Birmingham, AL
Background/Purpose: Assess the current management of patients with suspected heparin induced thrombocytopenia (HIT) in a community hospital due to the complex management of this disease, high risk medications involved, and potential for thrombosis if untreated.
Methodology: Charts were retrospectively reviewed for eligible participants including non-pregnant adults with suspected HIT. Patients with a history of HIT or those who died within 24 hours were excluded. The primary endpoint is the percentage of patients with suspected HIT managed appropriately within 24 hours, defined as ordering a PF4 antibody, discontinuing heparin analogues, and initiating fondaparinux or argatroban anticoagulation. Secondary endpoints include individual components of the primary endpoint, percentage of patients with PF4 antibody ordered with 4T scores
